BASF boosts API, excipient prices; Pfizer sells Capsugel to investor;

> BASF has increased the price of its APIs and drug excipients by 10 percent. Story

> Pfizer is selling its capsule-making unit, Capsugel, for $2.375 billion in cash to investment firm Kohlberg Kravis Roberts & Co.  Release

> India has approved a life sentence for anyone convicted of making fake drugs and distributing them in Nigeria. Item

> The Process Analytical Technology initiative will drive demand for instrumentation, says Frost and Sullivan. Story

> China's drug regulator, focused on improving drug safety, quality, and effectiveness, is turning to FDA regulations as a guide. Blog

> A top 10 drugmaker has selected Payne Security holographic tear tape for counterfeit protection and tamper evidence. Article

> For the second time in six years, Mylan Pharmaceuticals is expanding its distribution center in southeast Greensboro, NC, adding 162,400 square feet of space. News

> Supply chain service provider Tracelink says that half of Catalent Pharma Solutions' U.S. manufacturing sites have been added to its network. Report

> The consultancy Life Science Link has signed a deal with QuaDPharma for small scale pharmaceutical manufacturing services at Niagara Medical Campus in New York. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.